Braelin – BR10 – 19X8.5 – 5x108 – +25 mm – Noir lustré 235/45R18 98T XL Numéro de pièce ESSN1-1955016-84Q Marque 083282

Name: Braelin – BR10 – 19X8.5 – 5x108 – +25 mm – Noir lustré 235/45R18 98T XL Numéro de pièce ESSN1-1955016-84Q Marque 083282
Brand: ivancuevas.com
SKU: 29217239602
Price: 192.50 USD
Availability: InStock
Rating: 4.5427 (22 reviews)

SKU 29217239602 · ★ 4.5

EUR192.50EUR221.50

Pay in 4 interest-free payments of $48.12 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Nov 14 - Nov 19

Harbor notes

Description

Braelin – BR10 – 19X8.5 – 5x108 – +25 mm – Noir lustré 235 45R18 98T XL Numéro de pièce ESSN1 1955016 84Q Marque 083282 Numéro de pièce ESSN1 1955016 84Q Marque Nankang Modèle ESSN 1 Dimension 195 50R16 84Q Type Hiver Indice de charge 84 Indice de vitesse Q Flanc BSW Disponibilité En stock — disponible en 2 à 3 jours ouvrables Numéro de pièce BR16 1985 65BM+35C671 Marque Braelin Modèle BR16 Dimension 19X8 5 5x108mm +25 75 1 Fini Noir lustré Charge maximale 1521 lbs 690 kg Disponibilité En stock — disponible en 2 à 3 jours ouvrables

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

Frequently Asked Questions for Braelin – BR10 – 19X8.5 – 5x108 – +25 mm – Noir lustré 235/45R18 98T XL Numéro de pièce ESSN1-1955016-84Q Marque 083282

What should I check when reading a translated product listing?

Look for consistency between the final selection and the description you reviewed. Make the decision from verified meaning rather than the most favorable interpretation of translated wording.

How can I make a useful comparison table for several products?

Add relevant limitations alongside the positive features. Save the final comparison with the relevant purchase notes.

How can I check whether a purchase involves ongoing commitments?

Do not infer indefinite access or support from an unspecified term. Do not treat a trial label as a complete explanation of what follows it.